Improve efficiency while reducing costs in clinical trials with centralized monitoring techniques using JMP and SAS.
International guidelines recommend that clinical trial data should be actively reviewed or monitored; the well-being of trial participants and the validity and integrity of the final analysis results are at stake. Traditional interpretation of this guidance for pharmaceutical trials has led to extensive on-site monitoring, including 100% source data verification. On-site review is time consuming, expensive (estimated at up to a third of the cost of a clinical trial), prone to error, and limited in its ability to provide insight for data trends across time, patients, and clinical sites. In contrast, risk-based monitoring (RBM) makes use of central computerized review of clinical trial data and site metrics to determine if and when clinical sites should receive more extensive quality review or intervention.
Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS presents a practical implementation of methodologies within JMP Clinical for the centralized monitoring of clinical trials. Focused on intermediate users, this book describes analyses for RBM that incorporate and extend the recommendations of TransCelerate Biopharm Inc., methods to detect potential patient-or investigator misconduct, snapshot comparisons to more easily identify new or modified data, and other novel visual and analytical techniques to enhance safety and quality reviews. Further discussion highlights recent regulatory guidance documents on risk-based approaches, addresses the requirements for CDISC data, and describes methods to supplement analyses with data captured external to the study database.
Given the interactive, dynamic, and graphical nature of JMP Clinical, any individual from the clinical trial team - including clinicians, statisticians, data managers, programmers, regulatory associates, and monitors - can make use of this book and the numerous examples contained within to streamline, accelerate, and enrich their reviews of clinical trial data.
The analytical methods described in Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS enable the clinical trial team to take a proactive approach to data quality and safety to streamline clinical development activities and address shortcomings while the study is ongoing.
This book is part of the SAS Press Program.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Richard C. Zink is a Principal Research Statistician Developer in the JMP Life Sciences division at SAS Institute. He is a developer for JMP Clinical, an innovative software package designed to streamline the review of clinical trial data. He joined SAS in 2011 after eight years in the pharmaceutical industry, where he designed and analyzed clinical trials for patients diagnosed with chronic hepatitis B infection, chronic myeloid leukemia, glaucoma, dry eye disease, blepharitis, or cystic fibrosis; he also participated in US and European drug submissions and in two FDA advisory committee hearings. When not actively engaged in clinical development responsibilities, he supported non-clinical development, pharmaceutical sciences, and sales and marketing activities. Richard is a member of the Biopharmaceutical Section of the American Statistical Association, the Drug Information Association, and Statisticians in the Pharmaceutical Industry. He is currently the Statistics Section Editor for Therapeutic Innovation & Regulatory Science (formerly Drug Information Journal). His research interests include the analysis of pre- and post-market adverse events, subgroup identification for patients with enhanced treatment response, and risk-based monitoring and fraud detection in clinical trials. Richard holds a Ph.D. in Biostatistics from the University of North Carolina at Chapel Hill and has more than 20 years of SAS programming experience. This is his first book.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
EUR 7,33 expédition depuis Etats-Unis vers France
Destinations, frais et délaisEUR 4,62 expédition depuis Royaume-Uni vers France
Destinations, frais et délaisVendeur : ThriftBooks-Atlanta, AUSTELL, GA, Etats-Unis
Paperback. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.15. N° de réf. du vendeur G1612909914I4N00
Quantité disponible : 1 disponible(s)
Vendeur : ThriftBooks-Dallas, Dallas, TX, Etats-Unis
Paperback. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.15. N° de réf. du vendeur G1612909914I4N00
Quantité disponible : 1 disponible(s)
Vendeur : BooksRun, Philadelphia, PA, Etats-Unis
Paperback. Etat : Good. Ship within 24hrs. Satisfaction 100% guaranteed. APO/FPO addresses supported. N° de réf. du vendeur 1612909914-11-1
Quantité disponible : 1 disponible(s)
Vendeur : BooksRun, Philadelphia, PA, Etats-Unis
Paperback. Etat : Very Good. Ship within 24hrs. Satisfaction 100% guaranteed. APO/FPO addresses supported. N° de réf. du vendeur 1612909914-8-1
Quantité disponible : 1 disponible(s)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9781612909912_new
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9781612909912
Quantité disponible : Plus de 20 disponibles
Vendeur : Chiron Media, Wallingford, Royaume-Uni
PF. Etat : New. N° de réf. du vendeur 6666-IUK-9781612909912
Quantité disponible : 10 disponible(s)
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9781612909912
Quantité disponible : Plus de 20 disponibles
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
Paperback / softback. Etat : New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 498. N° de réf. du vendeur C9781612909912
Quantité disponible : Plus de 20 disponibles
Vendeur : moluna, Greven, Allemagne
Kartoniert / Broschiert. Etat : New. Über den AutorrnrnRichard C. Zink is a Principal Research Statistician Developer in the JMP Life Sciences division at SAS Institute. He is a developer for JMP Clinical, an innovative software package designed to streamline the review of cl. N° de réf. du vendeur 4245860
Quantité disponible : Plus de 20 disponibles